Effects of Assessment and Verbal Feedback on Physical Function and Exercise Adherence in Healthy Older Adults

NCT07437521 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2026-03-04

No results posted yet for this study

Summary

The goal of this pilot Randomized Controlled Trial (RCT) was to investigate whether the provision of periodic assessment and verbal feedback during an exercise program has an effect on adherence, physical function and self-perceived competence in healthy community-dwelling older adults, aged ≥65 years.

An exercise program with periodic assessment and individualized verbal feedback was compared to the same exercise program delivered without individualized assessment and feedback to determine differences in adherence, functional performance, and self-perceived ability in community-dwelling older adults.

Participants:

* participated in a structured exercise program for 12 weeks (2times/week)
* underwent periodic assessments and received verbal feedback (intervention group only).

Conditions

  • Older Adults (65 Years and Older)
  • Healthy Older Adults
  • Community Dwelling Older Adults

Interventions

BEHAVIORAL

Periodic assessment and individualized verbal feedback

Participants underwent 3 periodic assessments and received individualized verbal feedback on their progress.

Sponsors & Collaborators

  • University of West Attica

    lead OTHER

Principal Investigators

  • Vasiliki Sakellari, Professor · University of West Attica

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-10-25
Primary Completion
2026-02-02
Completion
2026-02-04

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07437521 on ClinicalTrials.gov